Volume: 12 Issue: 2
Year: 2024, Page: 70-74, Doi: https://doi.org/10.47799/pimr.1202.13
Received: June 6, 2024 Accepted: July 10, 2024 Published: Aug. 12, 2024
Tumours of the nerve system and skin are hallmarks of neurofibromatosis, a neurocutaneous condition. One class of inherited illnesses known as phakomatoses includes neurofibromatosis type 1 (NF1) or von Recklinghausen disease. It may show up anywhere in the body, including the skin, eyes, bones, and organs. We report a visually recorded seven cases of NF1 from same area. Every single patient had some kind of skin symptom. We describe the presence of several isolated neurofibromas, café au lait macules, axillary and inguinal freckling, neurological or cognitive dysfunction, and Lisch nodules in 100% of the eyes as ocular symptoms. Also, a rare occurrence of plexiform neuroma seen. Rare and familial presentation and similar cases in the same region, these findings collectively underscore the complex nature of the patient's medical presentation, necessitating a multidisciplinary approach to management and care.
Keywords: Axillary freckling, Lisch nodules, Neuroma, Neurofibromatosis (NF)
Le, C & Bedocs, P M . 2023. Neurofibromatosis. In: StatPearls [Internet]. Treasure Island (FL). StatPearls Publishing
National Organization for Rare Disorders (NORD) 2022. Neurofibromatosis 1. https://rarediseases.org/rare-diseases/neurofibromatosis-type-1-nf1/ (accessed 2024-02-24)
Friedman, Joseph M. . 1998. Neurofibromatosis 1. In: Adam, Margaret P., Feldman, Jay & Mirzaa, Ghayda M. , eds. GeneReviews® [Internet] (Updated 2022 Apr 21). Seattle (WA): University of Washington, Seattle
Ferner, R E & Gutmann, D H . 2013. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939–55.
Eoli, M, Saletti, V & Finocchiaro, G . 2019. Neurological malignancies in neurofibromatosis type 1. Curr Opin Oncol 31(6):554–61.
Korf, B.R. . 2020. Therapeutic Approaches for NF1. In: Gianluca, Tadini, Eric, Legius & Hilde, Brems , eds. Multidisciplinary Approach to Neurofibromatosis Type 1. (pp. 216-272) Springer, Cham 10.1007/978-3-319-92450-2-18
Ejerskov, C, Farholt, S, Nielsen, Fsk, Berg, I, Thomasen, S B & Udupi, A . 2023. Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study. Oncol Ther 11(1):97–110.
Senthilkumar, V A & Tripathy, K . 2023. Lisch Nodules. StatPearls [Internet].Treasure Island (FL).StatPearls Publishing
Jusue-Torres, I, Hulbert, A, Zakaria, J, Albain, K S, Hentz, C & Melian, E . 2021. EPID-04. THE NATURAL HISTORY OF NEUROFIBROMATOSIS-1, THE MONTEFIORE EXPERIENCE. Neuro Oncol. 23:86 https://dx.doi.org/10.1093/neuonc/noab196.337
Hirbe, A C & Gutmann, D H . 2014. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 13(8):834–877.
Javed, F, Ramalingam, S, Ahmed, H B, Gupta, B, Sundar, C & Qadri, T . 2014. Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review. Crit Rev Oncol Hematol 91(2):123–132.
Shapiro, S D, Abramovitch, K, Van Dis, M L, Skoczylas, L J, Langlais, R P & Jorgenson, R J . 1984. Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol. 58:493–501 https://pubmed.ncbi.nlm.nih.gov/6436765/
Bongiorno, M R, Pistone, G & Aricò, M . 2006. Manifestations of the tongue in Neurofibromatosis type 1. Oral Dis 12(2):125–134.
Ottenhoff, M J, Rietman, A B, Mous, S E, Plasschaert, E, Gawehns, D & Brems, H . 2020. Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1. Genetics in Medicine 22(5):889–97.
Sanchez, L D, Bui, A & Klesse, L J . 2021. Targeted Therapies for the Neurofibromatoses. Cancers (Basel) 13(23).
Babovic-Vuksanovic, D, Ballman, K, Michels, V, Mcgrann, P, Lindor, N & King, B . 2006. Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology 67(10):1860–1862.
Widemann, B C, Babovic-Vuksanovic, D, Dombi, E, Wolters, P L, Goldman, S & Martin, S . 2014. Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas. Pediatr Blood Cancer 61(9):1598–602.
©2024 (Guruprasad K Y) et al. This is an open-access journal, and arƟcles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
K Y G, Mohammed WJ, R KS. Cluster of Neurofibromatosis Cases in Remote Area of Northern Karnataka: A Case Series. Perspectives in Medical Research. 2024;12(2):70-74 DOI: 10.47799/pimr.1202.13